Association of the 3 principal loci (BCL11A, HMIP, and the β-globin gene cluster) with HbF levels
Genetic variants tested . | Tanzanian HbSS patients . | British HbSS patients . | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Locus . | SNP name . | Position* on chromosome . | Allele change . | Minor allele frequency . | Effect† of allele change . | P . | n . | Minor allele frequency . | Effect† of allele change . | P‡ . | n . |
Chromosome 2 | |||||||||||
BCL11A | rs11886868 | 60 573 750 | C → T | 0.26 | −0.406 | 3.0 × 10−30 | 1000 | 0.29 | −0.302 | 8.5 × 10−4 | 146 |
BCL11A | rs4671393 | 60 574 455 | A → G | 0.30 | −0.412 | 3.9 × 10−28 | 845 | 0.28 | −0.440 | 3.7 × 10−6 | 145 |
Chromosome 6 | |||||||||||
HMIP-1 | rs28384513 | 135 417 902 | A → C | 0.21 | −0.146 | 1.9 × 10−4§ | 1021 | 0.21 | +0.103 | .36 | 142 |
HMIP-2 | rs9376090 | 135 452 920 | T → C | 0.01 | +0.471 | .016 | 1021 | 0.02 | +0.581 | .058 | 147 |
HMIP-2 | rs9399137 | 135 460 710 | T → C | 0.01 | +0.668 | 8.3 × 10−6 | 975 | 0.07 | +0.529 | .006 | 126 |
HMIP-2 | rs9389269 | 135 468 851 | T → C | 0.03 | +0.400 | 1.4 × 10−5§ | 1016 | 0.04 | +0.461 | .031 | 146 |
HMIP-2 | rs9402686 | 135 469 509 | G → A | 0.06 | +0.342 | 1.6 × 10−4§ | 1013 | 0.04 | +0.460 | .031 | 146 |
HMIP-2 | rs9494142 | 135 473 333 | T → C | 0.13 | +0.085 | .060 | 1014 | 0.10 | +0.218 | .127 | 144 |
Chromosome 11 | |||||||||||
HBG2 | rs7482144‖ | 5 232 745 | G → A | 0.01 | +0.562 | 1.6 × 10−4 | 991 | 0.07 | +0.136 | .43 | 147 |
OR51B5/6 | rs5006884 | 5 329 827 | C → T | 0.05 | +0.164 | .024 | 957 | 0.13 | +0.217 | .15 | 145 |
Genetic variants tested . | Tanzanian HbSS patients . | British HbSS patients . | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Locus . | SNP name . | Position* on chromosome . | Allele change . | Minor allele frequency . | Effect† of allele change . | P . | n . | Minor allele frequency . | Effect† of allele change . | P‡ . | n . |
Chromosome 2 | |||||||||||
BCL11A | rs11886868 | 60 573 750 | C → T | 0.26 | −0.406 | 3.0 × 10−30 | 1000 | 0.29 | −0.302 | 8.5 × 10−4 | 146 |
BCL11A | rs4671393 | 60 574 455 | A → G | 0.30 | −0.412 | 3.9 × 10−28 | 845 | 0.28 | −0.440 | 3.7 × 10−6 | 145 |
Chromosome 6 | |||||||||||
HMIP-1 | rs28384513 | 135 417 902 | A → C | 0.21 | −0.146 | 1.9 × 10−4§ | 1021 | 0.21 | +0.103 | .36 | 142 |
HMIP-2 | rs9376090 | 135 452 920 | T → C | 0.01 | +0.471 | .016 | 1021 | 0.02 | +0.581 | .058 | 147 |
HMIP-2 | rs9399137 | 135 460 710 | T → C | 0.01 | +0.668 | 8.3 × 10−6 | 975 | 0.07 | +0.529 | .006 | 126 |
HMIP-2 | rs9389269 | 135 468 851 | T → C | 0.03 | +0.400 | 1.4 × 10−5§ | 1016 | 0.04 | +0.461 | .031 | 146 |
HMIP-2 | rs9402686 | 135 469 509 | G → A | 0.06 | +0.342 | 1.6 × 10−4§ | 1013 | 0.04 | +0.460 | .031 | 146 |
HMIP-2 | rs9494142 | 135 473 333 | T → C | 0.13 | +0.085 | .060 | 1014 | 0.10 | +0.218 | .127 | 144 |
Chromosome 11 | |||||||||||
HBG2 | rs7482144‖ | 5 232 745 | G → A | 0.01 | +0.562 | 1.6 × 10−4 | 991 | 0.07 | +0.136 | .43 | 147 |
OR51B5/6 | rs5006884 | 5 329 827 | C → T | 0.05 | +0.164 | .024 | 957 | 0.13 | +0.217 | .15 | 145 |
Representative SNPs for BCL11A on chromosome 2, the HBS1L-MYB intergenic polymorphism (HMIP) on chromosome 6, and HBG2 on chromosome 11, which encodes Gγ-globin are shown. rs7482144 has been extensively studied as the Xmn1 Gγ-polymorphism, a component of the classic sickle haplotypes, where the alternative allele A is detected as positive (site present, Senegal and Arab/Indian haplotypes). Allele frequencies in the patient population were derived from all genotyped individuals (n > 1300).
The chromosomal position given here is based on the public human genome assembly National Center for Biotechnology Information 36.1 (University of California Santa Cruz, genome browser21 ).
“+” or “−” indicates whether the allele change elevates or depresses HbF (expressed as ln[% HbF]). The value reported here (the regression coefficient β) indicates by how much the trait value changes, on average, when one of the alleles in a genotype is changed. This is also referred to as the additive allelic effect.
Although the allelic effect sizes (β) are often comparable between the 2 groups, P values are much larger in the British patients because of the smaller number of subjects studied.
Association with these makers remains significant at P < .001 after linkage disequilibrium with rs9399137 is taken into account (ie, these markers display HbF association independent of rs9399137).
rs7482144 is also referred to as the Xmn1-Gγ site, where “+” indicates the alternative allele A.